301201 诚达药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)0.785-1.2724.0517.76220.345
总资产报酬率 ROA (%)0.698-1.1493.8097.08716.500
投入资产回报率 ROIC (%)0.752-1.2294.0047.52918.666

边际利润分析
销售毛利率 (%)45.39142.82142.88648.00949.972
营业利润率 (%)6.682-7.37526.01930.19628.250
息税前利润/营业总收入 (%)6.341-9.37223.29927.87628.389
净利润/营业总收入 (%)5.890-8.29721.98925.87824.120

收益指标分析
经营活动净收益/利润总额(%)43.891220.51260.24871.29797.058
价值变动净收益/利润总额(%)71.377-119.15640.11933.0210.000
营业外收支净额/利润总额(%)-5.9849.614-3.404-3.445-1.871

偿债能力分析
流动比率 (X)7.3836.8449.57816.8761.529
速动比率 (X)6.5056.1908.81715.3050.824
资产负债率 (%)9.98011.9347.1854.55722.438
带息债务/全部投入资本 (%)3.6014.6081.7320.07711.773
股东权益/带息债务 (%)2,673.8612,066.1775,660.638129,661.467741.648
股东权益/负债合计 (%)900.886737.0351,290.8642,092.776345.234
利息保障倍数 (X)172.2627.730-12.503-21.21043.167

营运能力分析
应收账款周转天数 (天)94.698118.494100.94086.13265.545
存货周转天数 (天)250.910251.118218.244219.281140.335